Results 141 to 150 of about 7,679 (193)

Benralizumab reduces sputum ANCA in patients with eosinophilic granulomatosis with polyangiitis. [PDF]

open access: yesERJ Open Res
Mukherjee M   +18 more
europepmc   +1 more source

The Impact of BMI on the Effect of Biologic Agents for Severe Asthma. [PDF]

open access: yesPulm Ther
Papadopoulou S   +4 more
europepmc   +1 more source

Six-Month Benralizumab Maintenance for Relapsing Chronic Eosinophilic Pneumonia Guided by Eosinophil Kinetics. [PDF]

open access: yesRespirol Case Rep
Sumi T   +6 more
europepmc   +1 more source

Development of Pediatric Dosing for Mepolizumab in Severe Asthma Based on Extrapolation of Data From Adult Patients and a Phase II Open-Label Pediatric Trial. [PDF]

open access: yesJ Clin Pharmacol
Gupta A   +8 more
europepmc   +1 more source

Real-World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR). [PDF]

open access: yesClin Transl Allergy
Alobid I   +30 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy